1. Home
  2. AXSM vs TCBI Comparison

AXSM vs TCBI Comparison

Compare AXSM & TCBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • TCBI
  • Stock Information
  • Founded
  • AXSM 2012
  • TCBI 1996
  • Country
  • AXSM United States
  • TCBI United States
  • Employees
  • AXSM N/A
  • TCBI N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • TCBI Major Banks
  • Sector
  • AXSM Health Care
  • TCBI Finance
  • Exchange
  • AXSM Nasdaq
  • TCBI Nasdaq
  • Market Cap
  • AXSM 4.2B
  • TCBI 3.7B
  • IPO Year
  • AXSM 2015
  • TCBI N/A
  • Fundamental
  • Price
  • AXSM $137.75
  • TCBI $79.58
  • Analyst Decision
  • AXSM Strong Buy
  • TCBI Hold
  • Analyst Count
  • AXSM 14
  • TCBI 14
  • Target Price
  • AXSM $158.93
  • TCBI $79.36
  • AVG Volume (30 Days)
  • AXSM 1.1M
  • TCBI 428.4K
  • Earning Date
  • AXSM 02-18-2025
  • TCBI 04-17-2025
  • Dividend Yield
  • AXSM N/A
  • TCBI N/A
  • EPS Growth
  • AXSM N/A
  • TCBI N/A
  • EPS
  • AXSM N/A
  • TCBI 1.28
  • Revenue
  • AXSM $385,693,000.00
  • TCBI $865,346,000.00
  • Revenue This Year
  • AXSM $45.18
  • TCBI N/A
  • Revenue Next Year
  • AXSM $65.22
  • TCBI $9.16
  • P/E Ratio
  • AXSM N/A
  • TCBI $63.33
  • Revenue Growth
  • AXSM 42.53
  • TCBI N/A
  • 52 Week Low
  • AXSM $64.11
  • TCBI $54.68
  • 52 Week High
  • AXSM $139.13
  • TCBI $91.80
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 74.55
  • TCBI 46.42
  • Support Level
  • AXSM $124.04
  • TCBI $80.79
  • Resistance Level
  • AXSM $130.52
  • TCBI $82.72
  • Average True Range (ATR)
  • AXSM 5.78
  • TCBI 2.39
  • MACD
  • AXSM 1.11
  • TCBI -0.12
  • Stochastic Oscillator
  • AXSM 96.07
  • TCBI 42.53

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.

Share on Social Networks: